{
    "nct_id": "NCT02948569",
    "official_title": "Evaluation of 3-V Bioscience-2640, a FASN Inhibitor, to Reduce de Novo Lipogenesis in Subjects With Characteristics of the Metabolic Syndrome",
    "inclusion_criteria": "1. Men with characteristics of metabolic syndrome\n\n   1. Waist circumference greater than 40 in (102 cm)\n   2. Plasma TG greater than 150 mg/dL\n   3. HDL cholesterol less than 40 mg/dL\n   4. Blood pressure greater than or equal to 130/85 mmHg\n   5. Fasting plasma glucose greater than 100 mg/dL but less than 126 mg/dL\n   6. Fasting insulin great than 10 microunits/mL\n2. 35-60 years of age\n3. Overweight/obese subjects with BMI 27.1 - 35.0 kg/m2\n4. Family history of cardiovascular disease or diabetes\n5. Habitual diets containing ≥ 5.0% of energy from added sugars\n6. Creatinine clearance of ≥80 mL/min\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 35 Years\nMust have maximum age of 60 Years",
    "exclusion_criteria": "1. Diagnosed cardiovascular disease (unstable angina, New York Heart Association angina > Grade 2), abnormal thyroid function or liver/kidney disease, renal dysfunction (defined by a glomerular filtration rate <80 mL/min)\n2. Chronic skin disorder or treatment for acne\n3. History of clinically significant dry eye or eye diseases such as glaucoma\n4. Diabetes defined as fasting glucose ≥ 125 mg/dL or HbA1c ≥ 6.5%\n5. Habitual diets with low content of added sugars (<5% of total energy)\n6. Any tobacco use\n7. Elevated liver enzymes ≥ 3x normal (regional norms Alanine transaminase <42 U/L, aspartate aminotransferase <40 U/L, and gamma-glutamyl transferase 8-61 U/L)\n8. Contraindications of MRI\n9. Alcohol intake weekly greater than 56 g/week (4 standard drinks/wk).\n10. Major surgery or donation of blood of >500 mL within the past 8 wks.\n11. Patients with uncontrolled hypertension, i.e. ≥160/95 mmHg.\n12. Patients with known cardiac abnormalities.",
    "miscellaneous_criteria": ""
}